Bellevue Group AG acquired a new position in shares of Guardant Health Inc (NASDAQ:GH) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 109,117 shares of the company’s stock, valued at approximately $4,102,000.
Other large investors have also added to or reduced their stakes in the company. Benjamin F. Edwards & Company Inc. bought a new position in Guardant Health during the 4th quarter valued at about $26,000. Citigroup Inc. bought a new position in Guardant Health during the 4th quarter valued at about $94,000. Victory Capital Management Inc. bought a new position in Guardant Health during the 4th quarter valued at about $124,000. Pendal Group Ltd bought a new position in Guardant Health during the 4th quarter valued at about $213,000. Finally, Janney Montgomery Scott LLC bought a new position in Guardant Health during the 4th quarter valued at about $220,000. 5.81% of the stock is owned by institutional investors.
GH opened at $67.04 on Wednesday. Guardant Health Inc has a 1-year low of $27.04 and a 1-year high of $74.47.
Separately, Bank of America reissued a “neutral” rating and set a $60.00 price target (up from $42.00) on shares of Guardant Health in a report on Thursday, February 28th. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus price target of $51.00.
Guardant Health Company Profile
Guardant Health, Inc, a precision oncology company, provides non-invasive cancer diagnostics. It offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes from circulating tumor DNA (ctDNA); and GuardantOMNI, a broader panel measuring various genes from ctDNA.
Recommended Story: Special Dividends
Want to see what other hedge funds are holding GH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Guardant Health Inc (NASDAQ:GH).
Receive News & Ratings for Guardant Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardant Health and related companies with MarketBeat.com's FREE daily email newsletter.